MENU
BOLT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bolt Biotherapeutics (BOLT) Earnings Date & Reports
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more
A.I. Advisor
published Earnings
BOLT is expected to report earnings to fall 22.74% to -332 cents per share on August 12
Q2'26
Est.
$-3.33
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
Q2'25
Missed
by $4.15
The last earnings report on May 12 showed earnings per share of -430 cents, missing the estimate of -36 cents. With 22.18K shares outstanding, the current market capitalization sits at 7.80M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com